Position Statement on Intra-Articular Injections for Knee Osteoarthritis – 2019
The management of knee osteoarthritis and degenerative meniscal tears is multimodal. A key component to the non-operative management of these conditions involves intra-articular injection therapy. The injections available in Canada include: corticosteroids, hyaluronic acid (HA), platelet rich plasma (PRP), and stem cell injections including bone marrow aspirate concentrate (BMAC). The Arthroscopy Association of Canada (AAC), Canadian Arthroplasty Society (CAS) and Canadian Orthopaedic Association (COA) recently reviewed the most up to date evidence on the use of these injections.
See below for a brief synopsis of findings and recommendations, as well as the complete AAC position statement, with associated grades of recommendations and references.